Phase 1 study of JNJ-69086420, an actinium-225-labeled antibody targeting human kallikrein-2, for advanced prostate cancer Meeting Abstract
| Authors: | Morris, M. J.; Sartor, A. O.; Wong, J. Y. C.; Max, S. I.; Xie, H.; Russell, M.; Divgi, C. R.; Patricia, D.; Avadhani, A. N.; Nordquist, L. T. |
| Abstract Title: | Phase 1 study of JNJ-69086420, an actinium-225-labeled antibody targeting human kallikrein-2, for advanced prostate cancer |
| Meeting Title: | 2022 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2022 Feb 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-20 |
| Language: | English |
| ACCESSION: | WOS:000771008900211 |
| DOI: | 10.1200/JCO.2022.40.6_suppl.TPS206 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS206 -- Meeting was conducted online as well as in person -- Source: Wos |
